Ignite Creation Date:
2024-05-06 @ 5:53 PM
Last Modification Date:
2024-10-26 @ 2:37 PM
Study NCT ID:
NCT05461807
Status:
COMPLETED
Last Update Posted:
2022-10-26
First Post:
2022-07-14
Brief Title:
An Observational Study Called H2H-OSCAR-US to Learn More About How Well Rivaroxaban Works and How Safe it is Compared to Apixaban Under Real World Conditions in People in the US With Cancer Who Have Problems Due to Formation of Blood Clots in the Veins Venous Thromboembolism
Sponsor:
Organization:
Bayer